Screener
GeneDx Holdings WGS Other — Adjusted Gross Margin
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept wgs:AdjustedGrossMargin.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | Three months ended March 31, 2026 / Gene Dx | Three months ended March 31, 2026 / Other | Three months ended March 31, 2026 / Total | Three months ended March 31, 2025 / Gene Dx | Three months ended March 31, 2025 / Other | Three months ended March 31, 2025 / Total |
|---|---|---|---|---|---|---|
| Revenue | $101,496 | $758 | $102,254 | $87,115 | — | $87,115 |
| Adjusted cost of services | 31,613 | 588 | 32,201 | 27,396 | — | 27,396 |
| Adjusted gross profit(1) | 69,883 | 170 | 70,053 | 59,719 | — | 59,719 |
| Reconciliations: | ||||||
| Depreciation and amortization | 1,462 | 1,075 | ||||
| Stock-based compensation | 380 | 168 | ||||
| Gross profit | $68,211 | $58,476 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's other — adjusted gross margin?
- GeneDx Holdings (WGS) reported other — adjusted gross margin of $170K in Q1 2026.
- What does other — adjusted gross margin mean?
- This metric measures the profitability of the Other business segment after accounting for the direct costs of services, adjusted for non-recurring or non-cash charges. It indicates the segment's ability to generate profit from its revenue base before considering overhead, administrative, or corporate expenses. This figure serves as a key indicator of the underlying unit economics and pricing power of the segment's service offerings.
Ask your AI about GeneDx Holdings's other — adjusted gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude